tetano
Editor, Senior Moderator
J Infect Chemother
. 2022 Dec 15;S1341-321X(22)00327-0.
doi: 10.1016/j.jiac.2022.12.004. Online ahead of print.
Validation of a specialized evaluation system for COVID-19 in Japan: A retrospective, multicenter cohort study
Hiroki Furuhata[SUP] 1 [/SUP], Kenji Araki[SUP] 2 [/SUP]
Affiliations
Abstract
Introduction: Evaluation of a severity grade (SG) is important to classify patients for efficient use of limited medical resources. This study validates two existing evaluation systems for the prevention of the coronavirus disease 2019 (COVID-19) in Japan: a criterion of SG and a list of 14 specialized underlying diseases (SUDs).
Methods: A retrospective cohort was created using electronic medical records from 18 research institutes. The cohort includes 6,050 COVID-19 patients with two types of diagnosis information as follows: SG at hospitalization among mild, moderate I, moderate II, and severe and aggravation after hospitalization.
Results: A crude mortality rate and an aggravation rate increased by the worsening of SG in the COVID-19 cohort. The transition of the aggravation rate was notable for COVID-19 patients with SUD. A conditional probability of the mortality given the aggravation in the COVID-19 cohort was 87.4% compared to mild or moderate patients (approximately 21%-45%) who have the possibility of the aggravation. An odds ratio of the mortality and aggravation information about the SUD list was higher than other variables.
Conclusions: We demonstrated the possibility of improving the criteria of SG by including the SUD list for more effective operation of the criteria of SG. Furthermore, we demonstrated the importance of the prevention of the aggravation based on the conditional probability, and the possibility of predicting the aggravation using the risk factors.
Keywords: COVID-19; Infection; Severity; Underlying disease.
. 2022 Dec 15;S1341-321X(22)00327-0.
doi: 10.1016/j.jiac.2022.12.004. Online ahead of print.
Validation of a specialized evaluation system for COVID-19 in Japan: A retrospective, multicenter cohort study
Hiroki Furuhata[SUP] 1 [/SUP], Kenji Araki[SUP] 2 [/SUP]
Affiliations
- PMID: 36529450
- DOI: 10.1016/j.jiac.2022.12.004
Abstract
Introduction: Evaluation of a severity grade (SG) is important to classify patients for efficient use of limited medical resources. This study validates two existing evaluation systems for the prevention of the coronavirus disease 2019 (COVID-19) in Japan: a criterion of SG and a list of 14 specialized underlying diseases (SUDs).
Methods: A retrospective cohort was created using electronic medical records from 18 research institutes. The cohort includes 6,050 COVID-19 patients with two types of diagnosis information as follows: SG at hospitalization among mild, moderate I, moderate II, and severe and aggravation after hospitalization.
Results: A crude mortality rate and an aggravation rate increased by the worsening of SG in the COVID-19 cohort. The transition of the aggravation rate was notable for COVID-19 patients with SUD. A conditional probability of the mortality given the aggravation in the COVID-19 cohort was 87.4% compared to mild or moderate patients (approximately 21%-45%) who have the possibility of the aggravation. An odds ratio of the mortality and aggravation information about the SUD list was higher than other variables.
Conclusions: We demonstrated the possibility of improving the criteria of SG by including the SUD list for more effective operation of the criteria of SG. Furthermore, we demonstrated the importance of the prevention of the aggravation based on the conditional probability, and the possibility of predicting the aggravation using the risk factors.
Keywords: COVID-19; Infection; Severity; Underlying disease.